Beaney R P, Gibbs J S, Brooks D J, McKenzie C G, Joplin G F, Jones T
MRC Cyclotron Unit, Hammersmith Hospital, London, United Kingdom.
J Neurooncol. 1987;5(2):129-37. doi: 10.1007/BF02571301.
This study was undertaken to confirm the belief that modern day external beam radiotherapy for patients with pituitary tumours should not be associated with any ischaemic temporal lobe damage. Using the oxygen-15 steady state inhalation technique and positron emission tomography regional temporal lobe blood flow, oxygen extraction fraction and oxygen utilisation were measured in 10 normal volunteers and 11 patients with pituitary tumours treated by irradiation. The patients were studied between 1 and 10.9 years after radiotherapy. We found that temporal lobe oxygen utilisation in the irradiated group (mean 2.11 +/- 0.23 ml of O2/100 ml tissue/min) did not differ from the normal group (mean 2.13 +/- 0.26 ml of O2/100 ml tissue/min). This suggests that total doses of between 35 and 56 Gy, delivered in fractions of less than 2 Gy, can be given to a pituitary tumour without demonstrable damage to normal temporal lobe.
本研究旨在证实这样一种观点,即现代垂体瘤患者的外照射放疗不应与任何缺血性颞叶损伤相关。使用氧 - 15稳态吸入技术和正电子发射断层扫描测量了10名正常志愿者和11名接受放疗的垂体瘤患者的颞叶区域血流、氧摄取分数和氧利用率。这些患者在放疗后1至10.9年接受研究。我们发现,放疗组的颞叶氧利用率(平均2.11±0.23毫升O2/100毫升组织/分钟)与正常组(平均2.13±0.26毫升O2/100毫升组织/分钟)没有差异。这表明,以小于2Gy的分次剂量给予垂体瘤35至56Gy的总剂量,不会对正常颞叶造成明显损伤。